Effects of Naringin on Cardiomyocytes From a Rodent Model of Type 2 Diabetes.

Uryash, A; Mijares, A; Flores, V; Adams, J A; Lopez, J R

Uryash, A; Mijares, A; Flores, V; Adams, J A; Lopez, J R.

Afiliación

Uryash A; Department of Neonatology, Mount Sinai Medical Center, Miami, FL, United States.
Mijares A; Centro de Biofísica y Bioquímica, Instituto Venezolano de Investigaciones Científicas, Caracas, Venezuela.
Flores V; Department of Research, Mount Sinai Medical Center, Miami, FL, United States.
Adams JA; Department of Neonatology, Mount Sinai Medical Center, Miami, FL, United States.
Lopez JR; Department of Research, Mount Sinai Medical Center, Miami, FL, United States.

Front Pharmacol ; 12: 719268, 2021.

Article en En | MEDLINE | ID: mdl-34497520

Palabras clave

KATP channels; ROS; calcium; cardiomyopathy; diabetes; glibenclamide; naringin; nicorandil

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Pharmacol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google